A $550 Billion Reason to Buy Cerebras Stock
Cerebras (CBRS) debuted May 14, rising nearly 68% to close at $311.07 after an intraday high of $386.34, then later pulled back toward the low-$200s. After its post-IPO quiet period expired, analyst initiations and improved sentiment helped shares rebound mid-teens. In its amended S-1, Cerebras reported $510M revenue for 2025 (+76% YoY) and net profit of $237.8M, with $24.6B RPO. Mizuho initiated “Outperform” with a $300 target; other firms set targets of $250–$340.
Fundamentals and backlog math are the core bull case ahead of the June 23 earnings print; sentiment is also being re-ignited post-quiet period.
Cerebras disclosed amended S-1 figures: 2025 revenue $510M (+76% YoY), net profit $237.8M, and $24.6B RPO with ~$3.7B expected by end-2027.
Near-term volatility likely into 6/23 as traders weigh profitability/backlog vs. still-lossy consensus EPS.
Background
The article frames Cerebras’ post-IPO price action (debut surge, subsequent pullback) and then ties it to amended S-1 disclosures, backlog economics, and renewed analyst coverage after the quiet period expired.
Why it matters
Traders get a near-term catalyst (6/23 earnings) plus concrete backlog/revenue/profitability datapoints that can change how the market prices growth and inference adoption.
Market relevance
CBRS is positioned as a fast-inference AI chip play with improving fundamentals and a large backlog, but the market will likely focus on whether Q1 and FY26 losses narrow as expected.
Market effects
Reinforces the market narrative shift from training to inference/fast inference, potentially supporting AI-infrastructure and chip-inference peers’ sentiment.
No specific regional impact beyond US-listed AI chip/IPO sentiment.
AWS partnership and large data-center spend outlook tie into global hyperscaler capex expectations.
Alternative perspectives
Despite strong 2025 profitability and large RPO, the stock still faces execution risk and near-term earnings expectations remain loss-making (consensus loss $0.14 in Q1; -$1.20 for FY26).
RPO recognition timing (~15% by end-2027) may front-load or delay revenue visibility; valuation sensitivity after the IPO euphoria fade could amplify any earnings miss.
Key entities
- companyCerebras
Wafer-scale AI chipmaker; amended S-1 cites 2025 revenue/profitability and $24.6B RPO with recognition expectations through 2027.
- partnerAmazon (AWS)
Partnership to bring Cerebras systems into AWS data centers, expanding distribution.
- analyst_firmMizuho
Launched coverage with Outperform rating and $300 price target; highlights fast-inference market growth.